These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 604138)

  • 21. An 'in vitro' marker of attenuation for live influenza virus vaccine candidates.
    Mostow SR; Flatauer S; Martinko J
    Dev Biol Stand; 1975; 28():354-62. PubMed ID: 1126579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Influenza, the changing virus.
    Med J Aust; 1975 May; 1(18):547-8. PubMed ID: 49839
    [No Abstract]   [Full Text] [Related]  

  • 23. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay of influenza A virus haemagglutinin. II. Antigenic cross-reactions of influenza A (H3 subtype) viruses as determined by radioimmunoassay and haemagglutination inhibition tests.
    Russ G; Styk B; Varecková E; Mucha V; Poláková K; Blaskovic D
    Acta Virol; 1980 Jan; 24(1):12-22. PubMed ID: 6155774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency of influenza vaccines: mouse protection experiments in correlation to field studies in man.
    Bachmayer H; Liehl E; Schmidt G
    Dev Biol Stand; 1975; 28():336-9. PubMed ID: 1126577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic techniques for the production of influenza vaccines (author's transl)].
    Teti G
    Ann Sclavo; 1980; 22(1):34-9. PubMed ID: 7018413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemagglutinin relationships of Hong Kong(H3) and Asian(H2) influenza strains delineated by antigen-specific recombinants.
    Dowdle WR; Marine WM; Coleman M; Knez V
    J Gen Virol; 1972 Aug; 16(2):127-34. PubMed ID: 5072364
    [No Abstract]   [Full Text] [Related]  

  • 30. [Is there evidence for antigenic drift of influenza C viruses? (author's transl)].
    Gerth HJ; Bauer KH; Steinitz H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):47-56. PubMed ID: 1154916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.
    Ghendon YZ
    Bull World Health Organ; 1984; 62(3):493-9. PubMed ID: 6331910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A re-examination of the single radial haemolysis technique for the assay of influenza anti-neuraminidase antibodies in human sera.
    Callow KA; Beare AS
    Arch Virol; 1980; 65(1):25-35. PubMed ID: 7000036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic hybrids of influenza A viruses with surface antigens to order.
    Webster RG
    Virology; 1970 Nov; 42(3):633-42. PubMed ID: 5529980
    [No Abstract]   [Full Text] [Related]  

  • 34. Temperature-sensitive recombinants of influenzavirus B.
    Polezhaev FI; Aleksandrova GI
    Acta Virol; 1978 May; 22(3):253. PubMed ID: 27978
    [No Abstract]   [Full Text] [Related]  

  • 35. Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses.
    Easterday B; Laver WG; Pereira HG; Schild GC
    J Gen Virol; 1969 Jul; 5(1):83-91. PubMed ID: 4980901
    [No Abstract]   [Full Text] [Related]  

  • 36. Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.
    Beare AS; Schild GC; Craig JW
    Lancet; 1975 Oct; 2(7938):729-32. PubMed ID: 52768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. a. Influenza viruses].
    Nobusawa E; Nakajima K
    Nihon Rinsho; 1987 Oct; 45(10):2229-34. PubMed ID: 3448262
    [No Abstract]   [Full Text] [Related]  

  • 38. Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens.
    Murphy BR; Spring SB; Richman DD; Tierney EL; Kasel J; Chanock RM
    Virology; 1975 Aug; 66(2):533-41. PubMed ID: 1171556
    [No Abstract]   [Full Text] [Related]  

  • 39. Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man.
    Lobmann M; Delem A; Jovanovic D; Peetermans J
    J Hyg (Lond); 1981 Aug; 87(1):43-52. PubMed ID: 7019320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future influenza vaccines and the use of genetic recombinants.
    Kilbourne ED
    Bull World Health Organ; 1969; 41(3):643-5. PubMed ID: 5309489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.